Description
Book SynopsisThis updated third edition offers a comprehensive and comparative analysis of the technologies fueling the major life-enhancing improvements in healthcare globally, including the ingredients for their successful development and commercialisation. Based on solid research, it focuses on practical business strategy issues for executives and students.
Trade Review'Understanding the dynamics of the medical device industry has been extremely important to me. Perhaps more than in any other sector, future medical devices, and the promises they hold for real solutions, represent the true intersection of high technology and health care. The information in this book provides a great understanding of this complex industry - the challenges of creating, improving, distributing and competing in this space. The materials included in this book provide an excellent foundation for anyone looking to solve healthcare problems with the incredible technology available today. I highly recommend it.' Kevin R. Sayer, President and CEO, Dexcom, Inc.
'Anyone interested in the healthcare field, absolutely needs to read this book. The perspective across all aspects of our industry gives the reader a unique understanding of how it all fits together. As I read the book I felt like I was reliving my over 40 years in the industry. A must read for all of us in a company, building a company, or investing who are committed to making a difference for patients.' Mark Levin, Co-Founder and Partner, Third Rock Ventures
'We are in the midst of a revolution that is transforming the pharma and biotech sectors, their strategies, business models, and revenue models. This revolution is breaking down the barriers between these two sectors, relabeling them both as 'life sciences', and calling for new models of discovery and commercialization. This new edition, written by industry experts, chronicles these changes to provide unique insights and learnings, and identifies the skill sets needed to help lead these sectors through revolutionary times.' John Maraganore, CEO, Alnylam Pharmaceuticals
'This is an important and opportune time to study and understand the medical technology sector of the healthcare market. This book does an excellent job of simplifying this complicated subject into its unique elements, analyzing each in a clear, direct style that illuminates the key issues facing this rapidly changing industry. The discussion of the sources of, impediments to and changing attitude toward device innovation and regulation are particularly welcome. I recommend this astute analysis to healthcare executives, policymakers, investors, innovators and anyone else who wants to understand the critical importance and future direction of the medical technology industry and its innovation for patients around the world.' Michael Mussallem, Chairman and CEO, Edwards Life Sciences
Table of Contents1. Product suppliers in the health care value chain Lawton Robert Burns; 2. The pharmaceutical sector Richard T. Evans and Scott Hinds; 3. The biotechnology sector – therapeutics Cary G. Pfeffer; 4. New venture creation in biotechnology Jason Rhodes and Lawton Robert Burns; 5. The medical device sector Kurt H. Kruger and Max A. Kruger; 6. Financing medtech innovation Justin Klein; 7. The healthcare information technology sector Adam C. Powell and John Glaser.
